Medtronic PLC
Medtronic plc develops, manufactures, and sells device-based medical therapies to healthcare systems, physicians, clinicians, and patients in the United States, Ireland, and internationally. It operates through three segments: The Cardiovascular Portfolio, Neuroscience Portfolio, and Medical Surgical Portfolio. The Cardiovascular Portfolio segment offers implantable cardiac pacemakers, cardioverter defibrillators, and cardiac resynchronization therapy devices; cardiac ablation products; insertable cardiac monitor systems; TYRX products; and remote monitoring and patient-centered software. It also provides aortic valves, surgical valve replacement and repair products, endovascular stent grafts and accessories, and transcatheter pulmonary valves, left atrial appendage exclusion systems, extracorporeal membrane oxygenation (ECMO) systems and percutaneous coronary intervention products, percutaneous angioplasty balloons, and endovenous products. The Neuroscience Portfolio segment offers medical devices and implants, biologic solutions, spinal cord stimulation and brain modulation systems, implantable drug infusion systems, and interventional products, as well as nerve ablation system under the Accurian name. This segment offers its products for spinal surgeons, neurosurgeons, neurologists, pain management specialists, anesthesiologists, orthopedic surgeons, urologists, urogynecologists, and interventional radiologists, as well as ear, nose, and throat specialists, and energy surgical instruments. The Medical Surgical Portfolio segment offers surgical stapling devices, vessel sealing instruments, wound closure and electrosurgery products, AI-powered surgical video and analytics platform, robotic-assisted surgery products, hernia mechanical devices, mesh implants, gynecology products, gastrointestinal and hepatologic diagnostics and therapies, and therapies to treat diseases and conditions, and patient monitoring and airway management products, as well as insulin pumps and consumables, continuous glucose monitoring sys
- Chief executive
- Mr. Geoffrey Straub Martha
- Employees
- 95,000
- Sector
- Healthcare
- Industry
- Medical Devices
- Country
- US
- IPO date
- 1978-01-13
Profile observed 2026-09-08 03:07:54.252081+00 via eodhd.
Forecasts are available for Medtronic PLC's listed securities
A corporation provides context; forecasts attach to the exact market security and forecast target. Choose a related security below.
Identifiers & semantic identity
External identifiers, stable Library identity, and semantic-web assertions describe the same governed entity.
- Wikidata ID
- Q642189
- Google Knowledge Graph MID
- /m/03z4j3
- Official website
- https://www.medtronic.com/
- iPulse entity ID
- fundsubj_49ee4d81-28d3-5907-83c1-a09251c2f6bb
- Official Website Url
- https://www.medtronic.com/
- Wikipedia Url
- https://en.wikipedia.org/wiki/Medtronic
Relationship graph
2D · draggableThe blue forecastable node can receive forecast targets. Green context nodes explain who issues, owns, or hosts it.